News
-
-
-
PRESS RELEASE
AUSTRIAN POST IN Q1-3 2025: Revenue and earnings below the strong prior-year results but above 2023 levels
Austrian Post reports Q1-3 2025 revenue and earnings slightly below prior-year results but above 2023 levels. Challenges in mail and parcel business noted. CEO optimistic about performance -
-
PRESS RELEASE
Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
Evotec receives US$ 5m milestone payment from Bristol Myers Squibb for IND acceptance in protein degradation partnership, advancing drug candidate towards Phase 1 clinical trial -
-
PRESS RELEASE
Exasol Confirms Preliminary Figures for the First Nine Months of 2025 – Strong ARR Growth in Focus Industries
Exasol AG confirms strong ARR growth of 24% to EUR 26.9 million in focus industries for the first nine months of 2025. Revenue up by 8.9% to EUR 31.7 million driven by performance with customers in focus industries -
-
-
PRESS RELEASE
adesso increases sales by 13% to EUR 1.1 billion after 9M and EBITDA by a disproportionate 17% to EUR 77.9 million / Consolidated net income significantly improved to EUR 6.2 m (PY: EUR 2.5 million)
adesso SE reports 13% sales growth to EUR 1.1 billion, EBITDA up 17% to EUR 77.9 million after 9 months. Consolidated net income improves to EUR 6.2 million. Full-year forecast confirmed amid challenging economic environment
